Nevertheless, the import of these potential mechanisms in relation to tau in Alzheimer’s disease is still unclear, and our findings suggest that additional study of the IGF2BP3 locus may be warranted. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.